CA2316052A1 - Sustained release formulations of water soluble peptides - Google Patents
Sustained release formulations of water soluble peptides Download PDFInfo
- Publication number
- CA2316052A1 CA2316052A1 CA002316052A CA2316052A CA2316052A1 CA 2316052 A1 CA2316052 A1 CA 2316052A1 CA 002316052 A CA002316052 A CA 002316052A CA 2316052 A CA2316052 A CA 2316052A CA 2316052 A1 CA2316052 A1 CA 2316052A1
- Authority
- CA
- Canada
- Prior art keywords
- sustained release
- water soluble
- release formulations
- soluble peptides
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
A sustained release formulation of a peptide drug compound, preferably a somatostatin like octreotide, e.g. as a pamoate salt. The drug compound is present in a polymeric carrier, preferably a polylactide-co-glycolide, especially a poly(lactide-co-glycolide)glucose. The formulation is preferably a depot formulation in the form of a monolithic microparticle.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002535463A CA2535463A1 (en) | 1989-07-07 | 1990-07-05 | Octreotide-pamoate and its use in sustained release formulations of water soluble peptides |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37702389A | 1989-07-07 | 1989-07-07 | |
US377,023 | 1989-07-07 | ||
US41134789A | 1989-09-22 | 1989-09-22 | |
US411,347 | 1989-09-22 | ||
CA002020477A CA2020477C (en) | 1989-07-07 | 1990-07-05 | Sustained release formulations of water soluble peptides |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002020477A Division CA2020477C (en) | 1989-07-07 | 1990-07-05 | Sustained release formulations of water soluble peptides |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002535463A Division CA2535463A1 (en) | 1989-07-07 | 1990-07-05 | Octreotide-pamoate and its use in sustained release formulations of water soluble peptides |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2316052A1 true CA2316052A1 (en) | 1991-01-08 |
CA2316052C CA2316052C (en) | 2008-09-02 |
Family
ID=27168773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002316052A Expired - Lifetime CA2316052C (en) | 1989-07-07 | 1990-07-05 | Sustained release formulations of water soluble peptides |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2316052C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008142153A1 (en) * | 2007-05-24 | 2008-11-27 | Novartis Ag | An extended-release composition comprising a somatostatin derivative in microparticles |
US8999390B2 (en) | 2008-01-30 | 2015-04-07 | Novartis Ag | Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers |
EP3242318A1 (en) * | 2003-12-19 | 2017-11-08 | The University of North Carolina at Chapel Hill | Monodisperse micro-structure or nano-structure product |
CN111514118A (en) * | 2020-05-06 | 2020-08-11 | 南京林业大学 | Preparation method of glucose-modified polylactic acid stereocomplex drug-loaded microspheres and product |
-
1990
- 1990-07-05 CA CA002316052A patent/CA2316052C/en not_active Expired - Lifetime
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3242318A1 (en) * | 2003-12-19 | 2017-11-08 | The University of North Carolina at Chapel Hill | Monodisperse micro-structure or nano-structure product |
US10842748B2 (en) | 2003-12-19 | 2020-11-24 | The University Of North Carolina At Chapel Hill | Methods for fabricating isolated micro- or nano-structures using soft or imprint lithography |
US11642313B2 (en) | 2003-12-19 | 2023-05-09 | The University Of North Carolina At Chapel Hill | Methods for fabricating isolated micro- or nano-structures using soft or imprint lithography |
WO2008142153A1 (en) * | 2007-05-24 | 2008-11-27 | Novartis Ag | An extended-release composition comprising a somatostatin derivative in microparticles |
US9351923B2 (en) | 2007-05-24 | 2016-05-31 | Novartis Ag | Extended-release composition comprising a somatostatin derivative in microparticles |
EP3666263A1 (en) * | 2007-05-24 | 2020-06-17 | Recordati AG | An extended-release composition comprising a somatostatin derivative in microparticles |
US8999390B2 (en) | 2008-01-30 | 2015-04-07 | Novartis Ag | Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers |
CN111514118A (en) * | 2020-05-06 | 2020-08-11 | 南京林业大学 | Preparation method of glucose-modified polylactic acid stereocomplex drug-loaded microspheres and product |
Also Published As
Publication number | Publication date |
---|---|
CA2316052C (en) | 2008-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY106722A (en) | Sustained release formulations of water soluble peptides. | |
FI870155A0 (en) | Process for the preparation of solid drug preparations containing xanthan gum | |
CA2075878A1 (en) | Cyclic peptides and use thereof | |
US5044091B1 (en) | Method of preparing a freeze-dried formulation of a drug | |
CA2207078A1 (en) | Insulin derivatives with increased zinc binding | |
WO1995013297A3 (en) | Improved immunogenic compositions against human gastrin 17 | |
AU3125389A (en) | Intravaginal delivery of biologically active polypeptides | |
PH30995A (en) | Sustained release formulations of water soluble peptides. | |
UA35569C2 (en) | Composition for sustained release of pharmaceutically active peptide and method for its manufacture, method for preparing suspension for parenteral administration | |
CA2128199A1 (en) | Stable Solid Pharmaceutical Compositions Containing Enalapril Maleate | |
WO1998021237A3 (en) | Peptide compounds useful for modulating FGF receptor activity | |
HK1029124A1 (en) | Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them. | |
RU94005001A (en) | PEPTIDE BASED LYOPHYLIZATE | |
EP0211601A3 (en) | Stabilization of growth promoting hormones | |
CA2316052A1 (en) | Sustained release formulations of water soluble peptides | |
CA2356959A1 (en) | Water-insoluble drug delivery system | |
EP0369474A3 (en) | Pharmaceutical composition for the treatment of cerebral edema | |
WO1988003150A3 (en) | N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration | |
FI991120A (en) | Sustained-release compositions of water-soluble peptides | |
ZA9710254B (en) | LH-RH peptide analogues, their uses and pharmaceutical composition containing them. | |
ES2049617A1 (en) | Biodegradable microparticles or implant containing insoluble peptide salts | |
CA2021923A1 (en) | Pharmaceutical composition containing hydantoin derivative | |
RU96111534A (en) | FOOD BIOLOGICALLY ACTIVE ADDITION OF TINROSTIM-S | |
CS275014B2 (en) | Peptides with accumulated pair of basic amino acids | |
CA2315241A1 (en) | Protein rim2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |